Well, it seems that the news about the "partner" are coming out soon as previously expected.<g>
Biomira set to name vaccine co-marketer -- BusinessWeek
NEW YORK, April 5 (Reuters) - Biotechnology company Biomira Inc. <BIOM.O><BRA.TO> will name a partner to co-market its Theratope vaccine for metastatic breast cancer in a few weeks, according to the Inside Wall Street column in
BusinessWeek.
The partner, one of two big European drug makers, will pay $10 million upfront and acquire an equity stake in Edmonton, Canada-based Biomira, the magazine reports in in its April 16 issue, citing an investment manager.
Biomira has enrolled 903 patients for its Phase III clinical trial of the vaccine, the magazine reported.
Biomira officials could not immediately be reached for comment.
Shares of Biomira rose 5/16, or 5.5 percent, to $6 on the Nasdaq on Thursday,off a 52-week high of $12-7/8.
22:01 04-05-01
Good luck to all.
Bernard
P.S.:The news are also in Yahoo:
biz.yahoo.com |
